National Account Director: Rare Disease Market Access

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

pPharvaris is seeking a National Account Director to lead payer strategy and access initiatives across commercial payers, Medicaid, Medicare, VA/DoD, and PBMs. You will develop strategic payer plans, build relationships with senior executives, and guide cross-functional teams to align access with Pharvaris' launch goals. /ppIn this senior role, you will...

ppPharvarisis a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to potentially address all types of bradykinin-mediated angioedema. By targeting this clinically proven therapeutic target with novel, oral small molecules, the Pharvaris team is advancing new alternatives to injected therapiesfor the prevention and...